When do you recommend initiation of targeted therapies in active RA with history of malignancy?
What is your most and least preferred? In case of cancer in remission and in case of non-remission?
Answer from: at Academic Institution
In patient with RA and a history of malignancy, I generally recommend the same therapy that I would recommend in the absence of a malignancy history. This is consistent with the most recent ACR guidelines for the management of RA (Fraenkel et al., PMID 34101387). Consistent with FDA labeling, I'd ge...